MSOS 股价预测及 ETF 分析 - 分红·管理费·持仓·NAV·RSI·MACD | 美股今日
10月29日 7:44 PM ET（韩国 10/30 08:44）
详细指标表
| Category | US Equities - Factor & Thematic | Expense | 0.78% | Return% 1Y | -11.76% | Total Holdings | 25 | Perf Week | 0% | Volume | 2,310,603 |
| Asset Type | Equities (Stocks) | AUM | $751M | Return% 3Y | -14.55% | NAV | $4.05 | Perf Month | -9.73% | Avg Volume | 4.73M |
| ETF Type | US Equities | Dividend TTM | - | Return% 5Y | -32.81% | 52W High | -43.72% | Perf Quarter | -3.55% | Rel Volume | 0.49 |
| Active/Passive | Active | Div Gr. 3/5Y | - | Return% 10Y | - | 52W Low | 37.84% | Perf Half Y | -20.16% | Prev Close | $4.05 |
| IPO | 2020/9/2 | Flows% 1M | -6.3% | Return% SI | -25.44% | RSI (14) | 42.18 | Perf YTD | -13.56% | Price | $4.08 |
| Beta | 1.52 | Flows% 3M | -8.49% | Flows% YTD | -6.54% | Flows% 1Y | 2.16% | Perf Year | -9.73% | Volatility(W/M) | 4.6% 5.04% |
| SMA20 | -1.5% | SMA50 | -11.96% | SMA200 | -8.34% | ATR | 0.2 | ||||
AdvisorShares Pure US Cannabis ETF seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
前10大持仓占 基金的42%
TRLV TRULIEVE CANNABIS CORP 9.56% 
GLAS GLASS HOUSE BRANDS INC 0.93% 过去1年中， 处于中等水平
较一年最高价低 44%。
成交量低于平时。 相当于平均成交量的49%。
若长期持有， 出现亏损
如果5年前买入，现在的收益率是-84.9%。 同期标普500为+68%。
点击查看数字
价格 波动非常剧烈
最糟糕时（2021年2月）下跌了96%，至今尚未完全恢复。
点击查看数字
没有股息
目前还没有可分配的利润。
资金小幅流入
最近一年流入了相当于资产2.2%的新资金。
点击查看数字
